1. Home
  2. SES vs TNXP Comparison

SES vs TNXP Comparison

Compare SES & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SES
  • TNXP
  • Stock Information
  • Founded
  • SES 2012
  • TNXP 2007
  • Country
  • SES United States
  • TNXP United States
  • Employees
  • SES N/A
  • TNXP N/A
  • Industry
  • SES Auto Parts:O.E.M.
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SES Consumer Discretionary
  • TNXP Health Care
  • Exchange
  • SES Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • SES 384.0M
  • TNXP 335.6M
  • IPO Year
  • SES N/A
  • TNXP N/A
  • Fundamental
  • Price
  • SES $1.13
  • TNXP $26.99
  • Analyst Decision
  • SES Hold
  • TNXP Buy
  • Analyst Count
  • SES 3
  • TNXP 1
  • Target Price
  • SES $1.50
  • TNXP $70.00
  • AVG Volume (30 Days)
  • SES 3.9M
  • TNXP 1.9M
  • Earning Date
  • SES 10-30-2025
  • TNXP 08-11-2025
  • Dividend Yield
  • SES N/A
  • TNXP N/A
  • EPS Growth
  • SES N/A
  • TNXP N/A
  • EPS
  • SES N/A
  • TNXP N/A
  • Revenue
  • SES $11,360,000.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • SES $883.92
  • TNXP $21.19
  • Revenue Next Year
  • SES $159.98
  • TNXP $722.94
  • P/E Ratio
  • SES N/A
  • TNXP N/A
  • Revenue Growth
  • SES N/A
  • TNXP N/A
  • 52 Week Low
  • SES $0.20
  • TNXP $6.76
  • 52 Week High
  • SES $2.53
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • SES 53.23
  • TNXP 33.50
  • Support Level
  • SES $1.05
  • TNXP $25.33
  • Resistance Level
  • SES $1.22
  • TNXP $29.70
  • Average True Range (ATR)
  • SES 0.07
  • TNXP 2.39
  • MACD
  • SES -0.00
  • TNXP -1.28
  • Stochastic Oscillator
  • SES 54.45
  • TNXP 11.76

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: